Janet Therrien

Selumetinib in Children with Neurofibromatosis Type 1 and Asymptomatic Inoperable Plexiform Neurofibroma At Risk for Developing Tumor-Related Morbidity.

S. Steinberg, Michael Fisher, S. Paul, 2022, Neuro-oncology.

Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.

N. Ratner, B. Widemann, E. Dombi, 2016, The New England journal of medicine.

Selumetinib in Children with Inoperable Plexiform Neurofibromas.

Seth M Steinberg, David J Venzon, D Wade Clapp, 2020, The New England journal of medicine.

Bacteria influence mountain pine beetle brood development through interactions with symbiotic and antagonistic fungi: implications for climate-driven host range expansion

K. Raffa, N. Erbilgin, B. Aukema, 2015, Oecologia.

NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)

S. Steinberg, S. Paul, Malcolm A. Smith, 2018, Neuro-Oncology.

SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

S. Steinberg, S. Paul, Malcolm A. Smith, 2016 .

Selumetinib in Children with Inoperable Plexiform Neurofibromas.

S. Steinberg, S. Paul, D. Venzon, 2020, The New England journal of medicine.

Bacteria influence mountain pine beetle brood development through interactions with symbiotic and antagonistic fungi: implications for climate-driven host range expansion

K. Raffa, N. Erbilgin, B. Aukema, 2015, Oecologia.